CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
151 hedge funds and large institutions have $198M invested in Clovis Oncology, Inc. in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-4
Holders Change %
-2.58%
% of All Funds
2.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
54
Reduced
38
Closed
27
Calls
$4.29M
Puts
$5.93M
Net Calls
-$1.65M
Net Calls Change
-$874K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$4.13M |
| 2 |
State Street
Boston,
Massachusetts
|
$43.7M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$21.3M |
| 4 |
Rafferty Asset Management
New York
|
$3.61M |
| 5 |
Citigroup
New York
|
$2.77M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$27.4M |
| 2 |
Morgan Stanley
New York
|
$988K |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
$10.8M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
$1.19M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
$449K |
